Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy

Lung cancer is the second most common and the most lethal malignancy worldwide. It is estimated that lung cancer in never smokers (LCINS) accounts for 10-25% of cases, and its incidence is increasing according to recent data, although the reasons remain unclear. If considered alone, LCINS is the 7th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Alencar, Viviane Teixeira L., Figueiredo, Amanda B., Corassa, Marcelo, Gollob, Kenneth J., Cordeiro de Lima, Vladmir C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448988/
https://www.ncbi.nlm.nih.gov/pubmed/36091058
http://dx.doi.org/10.3389/fimmu.2022.984349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448988/
https://www.ncbi.nlm.nih.gov/pubmed/36091058
http://dx.doi.org/10.3389/fimmu.2022.984349

Ejemplares similares